Global Nuclear Drug for Therapeutic Market Research Report 2026(Status and Outlook)
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Nuclear Drug for Therapeutic market size was estimated at USD 2313.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 15.10% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Nuclear Drug for Therapeutic market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Nuclear Drug for Therapeutic market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Nuclear Drug for Therapeutic market.
Global Nuclear Drug for Therapeutic Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Bayer
Novartis
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant Radiopharma
Lantheus
Aurobindo Pharma
International Isotopes
Mundipharma
Market Segmentation (by Type)
Radium-223
Lutetium-177
Iodine-131
Other
Market Segmentation (by Application)
Thyroid
Bone Metastasis
Lymphoma
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Nuclear Drug for Therapeutic Market
Overview of the regional outlook of the Nuclear Drug for Therapeutic Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Nuclear Drug for Therapeutic Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Nuclear Drug for Therapeutic, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Nuclear Drug for Therapeutic market size was estimated at USD 2313.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 15.10% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Nuclear Drug for Therapeutic market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Nuclear Drug for Therapeutic market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Nuclear Drug for Therapeutic market.
Global Nuclear Drug for Therapeutic Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Bayer
Novartis
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant Radiopharma
Lantheus
Aurobindo Pharma
International Isotopes
Mundipharma
Market Segmentation (by Type)
Radium-223
Lutetium-177
Iodine-131
Other
Market Segmentation (by Application)
Thyroid
Bone Metastasis
Lymphoma
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Nuclear Drug for Therapeutic Market
Overview of the regional outlook of the Nuclear Drug for Therapeutic Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Nuclear Drug for Therapeutic Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Nuclear Drug for Therapeutic, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Nuclear Drug for Therapeutic
1.2 Key Market Segments
1.2.1 Nuclear Drug for Therapeutic Segment by Type
1.2.2 Nuclear Drug for Therapeutic Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NUCLEAR DRUG FOR THERAPEUTIC MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Nuclear Drug for Therapeutic Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Nuclear Drug for Therapeutic Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NUCLEAR DRUG FOR THERAPEUTIC MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Nuclear Drug for Therapeutic Product Life Cycle
3.3 Global Nuclear Drug for Therapeutic Sales by Manufacturers (2020-2025)
3.4 Global Nuclear Drug for Therapeutic Revenue Market Share by Manufacturers (2020-2025)
3.5 Nuclear Drug for Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Nuclear Drug for Therapeutic Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Nuclear Drug for Therapeutic Market Competitive Situation and Trends
3.8.1 Nuclear Drug for Therapeutic Market Concentration Rate
3.8.2 Global 5 and 10 Largest Nuclear Drug for Therapeutic Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NUCLEAR DRUG FOR THERAPEUTIC INDUSTRY CHAIN ANALYSIS
4.1 Nuclear Drug for Therapeutic Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NUCLEAR DRUG FOR THERAPEUTIC MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Nuclear Drug for Therapeutic Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Nuclear Drug for Therapeutic Market
5.7 ESG Ratings of Leading Companies
6 NUCLEAR DRUG FOR THERAPEUTIC MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nuclear Drug for Therapeutic Sales Market Share by Type (2020-2025)
6.3 Global Nuclear Drug for Therapeutic Market Size by Type (2020-2025)
6.4 Global Nuclear Drug for Therapeutic Price by Type (2020-2025)
7 NUCLEAR DRUG FOR THERAPEUTIC MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nuclear Drug for Therapeutic Market Sales by Application (2020-2025)
7.3 Global Nuclear Drug for Therapeutic Market Size (M USD) by Application (2020-2025)
7.4 Global Nuclear Drug for Therapeutic Sales Growth Rate by Application (2020-2025)
8 NUCLEAR DRUG FOR THERAPEUTIC MARKET SALES BY REGION
8.1 Global Nuclear Drug for Therapeutic Sales by Region
8.1.1 Global Nuclear Drug for Therapeutic Sales by Region
8.1.2 Global Nuclear Drug for Therapeutic Sales Market Share by Region
8.2 Global Nuclear Drug for Therapeutic Market Size by Region
8.2.1 Global Nuclear Drug for Therapeutic Market Size by Region
8.2.2 Global Nuclear Drug for Therapeutic Market Size by Region
8.3 North America
8.3.1 North America Nuclear Drug for Therapeutic Sales by Country
8.3.2 North America Nuclear Drug for Therapeutic Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Nuclear Drug for Therapeutic Sales by Country
8.4.2 Europe Nuclear Drug for Therapeutic Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Nuclear Drug for Therapeutic Sales by Region
8.5.2 Asia Pacific Nuclear Drug for Therapeutic Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Nuclear Drug for Therapeutic Sales by Country
8.6.2 South America Nuclear Drug for Therapeutic Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Nuclear Drug for Therapeutic Sales by Region
8.7.2 Middle East and Africa Nuclear Drug for Therapeutic Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NUCLEAR DRUG FOR THERAPEUTIC MARKET PRODUCTION BY REGION
9.1 Global Production of Nuclear Drug for Therapeutic by Region(2020-2025)
9.2 Global Nuclear Drug for Therapeutic Revenue Market Share by Region (2020-2025)
9.3 Global Nuclear Drug for Therapeutic Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Nuclear Drug for Therapeutic Production
9.4.1 North America Nuclear Drug for Therapeutic Production Growth Rate (2020-2025)
9.4.2 North America Nuclear Drug for Therapeutic Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Nuclear Drug for Therapeutic Production
9.5.1 Europe Nuclear Drug for Therapeutic Production Growth Rate (2020-2025)
9.5.2 Europe Nuclear Drug for Therapeutic Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Nuclear Drug for Therapeutic Production (2020-2025)
9.6.1 Japan Nuclear Drug for Therapeutic Production Growth Rate (2020-2025)
9.6.2 Japan Nuclear Drug for Therapeutic Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Nuclear Drug for Therapeutic Production (2020-2025)
9.7.1 China Nuclear Drug for Therapeutic Production Growth Rate (2020-2025)
9.7.2 China Nuclear Drug for Therapeutic Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Bayer
10.1.1 Bayer Basic Information
10.1.2 Bayer Nuclear Drug for Therapeutic Product Overview
10.1.3 Bayer Nuclear Drug for Therapeutic Product Market Performance
10.1.4 Bayer Business Overview
10.1.5 Bayer SWOT Analysis
10.1.6 Bayer Recent Developments
10.2 Novartis
10.2.1 Novartis Basic Information
10.2.2 Novartis Nuclear Drug for Therapeutic Product Overview
10.2.3 Novartis Nuclear Drug for Therapeutic Product Market Performance
10.2.4 Novartis Business Overview
10.2.5 Novartis SWOT Analysis
10.2.6 Novartis Recent Developments
10.3 China Isotope and Radiation
10.3.1 China Isotope and Radiation Basic Information
10.3.2 China Isotope and Radiation Nuclear Drug for Therapeutic Product Overview
10.3.3 China Isotope and Radiation Nuclear Drug for Therapeutic Product Market Performance
10.3.4 China Isotope and Radiation Business Overview
10.3.5 China Isotope and Radiation SWOT Analysis
10.3.6 China Isotope and Radiation Recent Developments
10.4 Dongcheng
10.4.1 Dongcheng Basic Information
10.4.2 Dongcheng Nuclear Drug for Therapeutic Product Overview
10.4.3 Dongcheng Nuclear Drug for Therapeutic Product Market Performance
10.4.4 Dongcheng Business Overview
10.4.5 Dongcheng Recent Developments
10.5 Q BioMed
10.5.1 Q BioMed Basic Information
10.5.2 Q BioMed Nuclear Drug for Therapeutic Product Overview
10.5.3 Q BioMed Nuclear Drug for Therapeutic Product Market Performance
10.5.4 Q BioMed Business Overview
10.5.5 Q BioMed Recent Developments
10.6 Curium Pharmaceuticals
10.6.1 Curium Pharmaceuticals Basic Information
10.6.2 Curium Pharmaceuticals Nuclear Drug for Therapeutic Product Overview
10.6.3 Curium Pharmaceuticals Nuclear Drug for Therapeutic Product Market Performance
10.6.4 Curium Pharmaceuticals Business Overview
10.6.5 Curium Pharmaceuticals Recent Developments
10.7 Jubilant Radiopharma
10.7.1 Jubilant Radiopharma Basic Information
10.7.2 Jubilant Radiopharma Nuclear Drug for Therapeutic Product Overview
10.7.3 Jubilant Radiopharma Nuclear Drug for Therapeutic Product Market Performance
10.7.4 Jubilant Radiopharma Business Overview
10.7.5 Jubilant Radiopharma Recent Developments
10.8 Lantheus
10.8.1 Lantheus Basic Information
10.8.2 Lantheus Nuclear Drug for Therapeutic Product Overview
10.8.3 Lantheus Nuclear Drug for Therapeutic Product Market Performance
10.8.4 Lantheus Business Overview
10.8.5 Lantheus Recent Developments
10.9 Aurobindo Pharma
10.9.1 Aurobindo Pharma Basic Information
10.9.2 Aurobindo Pharma Nuclear Drug for Therapeutic Product Overview
10.9.3 Aurobindo Pharma Nuclear Drug for Therapeutic Product Market Performance
10.9.4 Aurobindo Pharma Business Overview
10.9.5 Aurobindo Pharma Recent Developments
10.10 International Isotopes
10.10.1 International Isotopes Basic Information
10.10.2 International Isotopes Nuclear Drug for Therapeutic Product Overview
10.10.3 International Isotopes Nuclear Drug for Therapeutic Product Market Performance
10.10.4 International Isotopes Business Overview
10.10.5 International Isotopes Recent Developments
10.11 Mundipharma
10.11.1 Mundipharma Basic Information
10.11.2 Mundipharma Nuclear Drug for Therapeutic Product Overview
10.11.3 Mundipharma Nuclear Drug for Therapeutic Product Market Performance
10.11.4 Mundipharma Business Overview
10.11.5 Mundipharma Recent Developments
11 NUCLEAR DRUG FOR THERAPEUTIC MARKET FORECAST BY REGION
11.1 Global Nuclear Drug for Therapeutic Market Size Forecast
11.2 Global Nuclear Drug for Therapeutic Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Nuclear Drug for Therapeutic Market Size Forecast by Country
11.2.3 Asia Pacific Nuclear Drug for Therapeutic Market Size Forecast by Region
11.2.4 South America Nuclear Drug for Therapeutic Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Nuclear Drug for Therapeutic by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Nuclear Drug for Therapeutic Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Nuclear Drug for Therapeutic by Type (2026-2035)
12.1.2 Global Nuclear Drug for Therapeutic Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Nuclear Drug for Therapeutic by Type (2026-2035)
12.2 Global Nuclear Drug for Therapeutic Market Forecast by Application (2026-2035)
12.2.1 Global Nuclear Drug for Therapeutic Sales (K MT) Forecast by Application
12.2.2 Global Nuclear Drug for Therapeutic Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Nuclear Drug for Therapeutic
1.2 Key Market Segments
1.2.1 Nuclear Drug for Therapeutic Segment by Type
1.2.2 Nuclear Drug for Therapeutic Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NUCLEAR DRUG FOR THERAPEUTIC MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Nuclear Drug for Therapeutic Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Nuclear Drug for Therapeutic Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NUCLEAR DRUG FOR THERAPEUTIC MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Nuclear Drug for Therapeutic Product Life Cycle
3.3 Global Nuclear Drug for Therapeutic Sales by Manufacturers (2020-2025)
3.4 Global Nuclear Drug for Therapeutic Revenue Market Share by Manufacturers (2020-2025)
3.5 Nuclear Drug for Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Nuclear Drug for Therapeutic Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Nuclear Drug for Therapeutic Market Competitive Situation and Trends
3.8.1 Nuclear Drug for Therapeutic Market Concentration Rate
3.8.2 Global 5 and 10 Largest Nuclear Drug for Therapeutic Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NUCLEAR DRUG FOR THERAPEUTIC INDUSTRY CHAIN ANALYSIS
4.1 Nuclear Drug for Therapeutic Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NUCLEAR DRUG FOR THERAPEUTIC MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Nuclear Drug for Therapeutic Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Nuclear Drug for Therapeutic Market
5.7 ESG Ratings of Leading Companies
6 NUCLEAR DRUG FOR THERAPEUTIC MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nuclear Drug for Therapeutic Sales Market Share by Type (2020-2025)
6.3 Global Nuclear Drug for Therapeutic Market Size by Type (2020-2025)
6.4 Global Nuclear Drug for Therapeutic Price by Type (2020-2025)
7 NUCLEAR DRUG FOR THERAPEUTIC MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nuclear Drug for Therapeutic Market Sales by Application (2020-2025)
7.3 Global Nuclear Drug for Therapeutic Market Size (M USD) by Application (2020-2025)
7.4 Global Nuclear Drug for Therapeutic Sales Growth Rate by Application (2020-2025)
8 NUCLEAR DRUG FOR THERAPEUTIC MARKET SALES BY REGION
8.1 Global Nuclear Drug for Therapeutic Sales by Region
8.1.1 Global Nuclear Drug for Therapeutic Sales by Region
8.1.2 Global Nuclear Drug for Therapeutic Sales Market Share by Region
8.2 Global Nuclear Drug for Therapeutic Market Size by Region
8.2.1 Global Nuclear Drug for Therapeutic Market Size by Region
8.2.2 Global Nuclear Drug for Therapeutic Market Size by Region
8.3 North America
8.3.1 North America Nuclear Drug for Therapeutic Sales by Country
8.3.2 North America Nuclear Drug for Therapeutic Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Nuclear Drug for Therapeutic Sales by Country
8.4.2 Europe Nuclear Drug for Therapeutic Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Nuclear Drug for Therapeutic Sales by Region
8.5.2 Asia Pacific Nuclear Drug for Therapeutic Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Nuclear Drug for Therapeutic Sales by Country
8.6.2 South America Nuclear Drug for Therapeutic Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Nuclear Drug for Therapeutic Sales by Region
8.7.2 Middle East and Africa Nuclear Drug for Therapeutic Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NUCLEAR DRUG FOR THERAPEUTIC MARKET PRODUCTION BY REGION
9.1 Global Production of Nuclear Drug for Therapeutic by Region(2020-2025)
9.2 Global Nuclear Drug for Therapeutic Revenue Market Share by Region (2020-2025)
9.3 Global Nuclear Drug for Therapeutic Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Nuclear Drug for Therapeutic Production
9.4.1 North America Nuclear Drug for Therapeutic Production Growth Rate (2020-2025)
9.4.2 North America Nuclear Drug for Therapeutic Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Nuclear Drug for Therapeutic Production
9.5.1 Europe Nuclear Drug for Therapeutic Production Growth Rate (2020-2025)
9.5.2 Europe Nuclear Drug for Therapeutic Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Nuclear Drug for Therapeutic Production (2020-2025)
9.6.1 Japan Nuclear Drug for Therapeutic Production Growth Rate (2020-2025)
9.6.2 Japan Nuclear Drug for Therapeutic Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Nuclear Drug for Therapeutic Production (2020-2025)
9.7.1 China Nuclear Drug for Therapeutic Production Growth Rate (2020-2025)
9.7.2 China Nuclear Drug for Therapeutic Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Bayer
10.1.1 Bayer Basic Information
10.1.2 Bayer Nuclear Drug for Therapeutic Product Overview
10.1.3 Bayer Nuclear Drug for Therapeutic Product Market Performance
10.1.4 Bayer Business Overview
10.1.5 Bayer SWOT Analysis
10.1.6 Bayer Recent Developments
10.2 Novartis
10.2.1 Novartis Basic Information
10.2.2 Novartis Nuclear Drug for Therapeutic Product Overview
10.2.3 Novartis Nuclear Drug for Therapeutic Product Market Performance
10.2.4 Novartis Business Overview
10.2.5 Novartis SWOT Analysis
10.2.6 Novartis Recent Developments
10.3 China Isotope and Radiation
10.3.1 China Isotope and Radiation Basic Information
10.3.2 China Isotope and Radiation Nuclear Drug for Therapeutic Product Overview
10.3.3 China Isotope and Radiation Nuclear Drug for Therapeutic Product Market Performance
10.3.4 China Isotope and Radiation Business Overview
10.3.5 China Isotope and Radiation SWOT Analysis
10.3.6 China Isotope and Radiation Recent Developments
10.4 Dongcheng
10.4.1 Dongcheng Basic Information
10.4.2 Dongcheng Nuclear Drug for Therapeutic Product Overview
10.4.3 Dongcheng Nuclear Drug for Therapeutic Product Market Performance
10.4.4 Dongcheng Business Overview
10.4.5 Dongcheng Recent Developments
10.5 Q BioMed
10.5.1 Q BioMed Basic Information
10.5.2 Q BioMed Nuclear Drug for Therapeutic Product Overview
10.5.3 Q BioMed Nuclear Drug for Therapeutic Product Market Performance
10.5.4 Q BioMed Business Overview
10.5.5 Q BioMed Recent Developments
10.6 Curium Pharmaceuticals
10.6.1 Curium Pharmaceuticals Basic Information
10.6.2 Curium Pharmaceuticals Nuclear Drug for Therapeutic Product Overview
10.6.3 Curium Pharmaceuticals Nuclear Drug for Therapeutic Product Market Performance
10.6.4 Curium Pharmaceuticals Business Overview
10.6.5 Curium Pharmaceuticals Recent Developments
10.7 Jubilant Radiopharma
10.7.1 Jubilant Radiopharma Basic Information
10.7.2 Jubilant Radiopharma Nuclear Drug for Therapeutic Product Overview
10.7.3 Jubilant Radiopharma Nuclear Drug for Therapeutic Product Market Performance
10.7.4 Jubilant Radiopharma Business Overview
10.7.5 Jubilant Radiopharma Recent Developments
10.8 Lantheus
10.8.1 Lantheus Basic Information
10.8.2 Lantheus Nuclear Drug for Therapeutic Product Overview
10.8.3 Lantheus Nuclear Drug for Therapeutic Product Market Performance
10.8.4 Lantheus Business Overview
10.8.5 Lantheus Recent Developments
10.9 Aurobindo Pharma
10.9.1 Aurobindo Pharma Basic Information
10.9.2 Aurobindo Pharma Nuclear Drug for Therapeutic Product Overview
10.9.3 Aurobindo Pharma Nuclear Drug for Therapeutic Product Market Performance
10.9.4 Aurobindo Pharma Business Overview
10.9.5 Aurobindo Pharma Recent Developments
10.10 International Isotopes
10.10.1 International Isotopes Basic Information
10.10.2 International Isotopes Nuclear Drug for Therapeutic Product Overview
10.10.3 International Isotopes Nuclear Drug for Therapeutic Product Market Performance
10.10.4 International Isotopes Business Overview
10.10.5 International Isotopes Recent Developments
10.11 Mundipharma
10.11.1 Mundipharma Basic Information
10.11.2 Mundipharma Nuclear Drug for Therapeutic Product Overview
10.11.3 Mundipharma Nuclear Drug for Therapeutic Product Market Performance
10.11.4 Mundipharma Business Overview
10.11.5 Mundipharma Recent Developments
11 NUCLEAR DRUG FOR THERAPEUTIC MARKET FORECAST BY REGION
11.1 Global Nuclear Drug for Therapeutic Market Size Forecast
11.2 Global Nuclear Drug for Therapeutic Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Nuclear Drug for Therapeutic Market Size Forecast by Country
11.2.3 Asia Pacific Nuclear Drug for Therapeutic Market Size Forecast by Region
11.2.4 South America Nuclear Drug for Therapeutic Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Nuclear Drug for Therapeutic by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Nuclear Drug for Therapeutic Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Nuclear Drug for Therapeutic by Type (2026-2035)
12.1.2 Global Nuclear Drug for Therapeutic Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Nuclear Drug for Therapeutic by Type (2026-2035)
12.2 Global Nuclear Drug for Therapeutic Market Forecast by Application (2026-2035)
12.2.1 Global Nuclear Drug for Therapeutic Sales (K MT) Forecast by Application
12.2.2 Global Nuclear Drug for Therapeutic Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Nuclear Drug for Therapeutic Market Size by Type (M USD)
Table 4. Global Nuclear Drug for Therapeutic Market Size by Application
Table 5. Nuclear Drug for Therapeutic Market Size Comparison by Region (M USD)
Table 6. Global Nuclear Drug for Therapeutic Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Nuclear Drug for Therapeutic Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Nuclear Drug for Therapeutic Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Nuclear Drug for Therapeutic Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Drug for Therapeutic as of 2025)
Table 11. Global Market Nuclear Drug for Therapeutic Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Nuclear Drug for Therapeutic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Nuclear Drug for Therapeutic Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Nuclear Drug for Therapeutic Sales by Type (K MT)
Table 27. Global Nuclear Drug for Therapeutic Market Size by Type (M USD)
Table 28. Global Nuclear Drug for Therapeutic Sales (K MT) by Type (2020-2025)
Table 29. Global Nuclear Drug for Therapeutic Sales Market Share by Type (2020-2025)
Table 30. Global Nuclear Drug for Therapeutic Market Size (M USD) by Type (2020-2025)
Table 31. Global Nuclear Drug for Therapeutic Market Share by Type (2020-2025)
Table 32. Global Nuclear Drug for Therapeutic Price (USD/KG) by Type (2020-2025)
Table 33. Global Nuclear Drug for Therapeutic Sales (K MT) by Application
Table 34. Global Nuclear Drug for Therapeutic Market Size by Application
Table 35. Global Nuclear Drug for Therapeutic Sales by Application (2020-2025) & (K MT)
Table 36. Global Nuclear Drug for Therapeutic Sales Market Share by Application (2020-2025)
Table 37. Global Nuclear Drug for Therapeutic Market Size by Application (2020-2025) & (M USD)
Table 38. Global Nuclear Drug for Therapeutic Market Share by Application (2020-2025)
Table 39. Global Nuclear Drug for Therapeutic Sales Growth Rate by Application (2020-2025)
Table 40. Global Nuclear Drug for Therapeutic Sales by Region (2020-2025) & (K MT)
Table 41. Global Nuclear Drug for Therapeutic Sales Market Share by Region (2020-2025)
Table 42. Global Nuclear Drug for Therapeutic Market Size by Region (2020-2025) & (M USD)
Table 43. Global Nuclear Drug for Therapeutic Market Size by Region (2020-2025)
Table 44. North America Nuclear Drug for Therapeutic Sales by Country (2020-2025) & (K MT)
Table 45. North America Nuclear Drug for Therapeutic Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Nuclear Drug for Therapeutic Sales by Country (2020-2025) & (K MT)
Table 47. Europe Nuclear Drug for Therapeutic Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Nuclear Drug for Therapeutic Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Nuclear Drug for Therapeutic Market Size by Region (2020-2025) & (M USD)
Table 50. South America Nuclear Drug for Therapeutic Sales by Country (2020-2025) & (K MT)
Table 51. South America Nuclear Drug for Therapeutic Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Nuclear Drug for Therapeutic Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Nuclear Drug for Therapeutic Market Size by Region (2020-2025) & (M USD)
Table 54. Global Nuclear Drug for Therapeutic Production (K MT) by Region(2020-2025)
Table 55. Global Nuclear Drug for Therapeutic Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Nuclear Drug for Therapeutic Revenue Market Share by Region (2020-2025)
Table 57. Global Nuclear Drug for Therapeutic Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Nuclear Drug for Therapeutic Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Nuclear Drug for Therapeutic Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Nuclear Drug for Therapeutic Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Nuclear Drug for Therapeutic Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Bayer Basic Information
Table 63. Bayer Nuclear Drug for Therapeutic Product Overview
Table 64. Bayer Nuclear Drug for Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Bayer Business Overview
Table 66. Bayer SWOT Analysis
Table 67. Bayer Recent Developments
Table 68. Novartis Basic Information
Table 69. Novartis Nuclear Drug for Therapeutic Product Overview
Table 70. Novartis Nuclear Drug for Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Novartis Business Overview
Table 72. Novartis SWOT Analysis
Table 73. Novartis Recent Developments
Table 74. China Isotope and Radiation Basic Information
Table 75. China Isotope and Radiation Nuclear Drug for Therapeutic Product Overview
Table 76. China Isotope and Radiation Nuclear Drug for Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. China Isotope and Radiation Business Overview
Table 78. China Isotope and Radiation SWOT Analysis
Table 79. China Isotope and Radiation Recent Developments
Table 80. Dongcheng Basic Information
Table 81. Dongcheng Nuclear Drug for Therapeutic Product Overview
Table 82. Dongcheng Nuclear Drug for Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Dongcheng Business Overview
Table 84. Dongcheng Recent Developments
Table 85. Q BioMed Basic Information
Table 86. Q BioMed Nuclear Drug for Therapeutic Product Overview
Table 87. Q BioMed Nuclear Drug for Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Q BioMed Business Overview
Table 89. Q BioMed Recent Developments
Table 90. Curium Pharmaceuticals Basic Information
Table 91. Curium Pharmaceuticals Nuclear Drug for Therapeutic Product Overview
Table 92. Curium Pharmaceuticals Nuclear Drug for Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Curium Pharmaceuticals Business Overview
Table 94. Curium Pharmaceuticals Recent Developments
Table 95. Jubilant Radiopharma Basic Information
Table 96. Jubilant Radiopharma Nuclear Drug for Therapeutic Product Overview
Table 97. Jubilant Radiopharma Nuclear Drug for Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Jubilant Radiopharma Business Overview
Table 99. Jubilant Radiopharma Recent Developments
Table 100. Lantheus Basic Information
Table 101. Lantheus Nuclear Drug for Therapeutic Product Overview
Table 102. Lantheus Nuclear Drug for Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Lantheus Business Overview
Table 104. Lantheus Recent Developments
Table 105. Aurobindo Pharma Basic Information
Table 106. Aurobindo Pharma Nuclear Drug for Therapeutic Product Overview
Table 107. Aurobindo Pharma Nuclear Drug for Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Aurobindo Pharma Business Overview
Table 109. Aurobindo Pharma Recent Developments
Table 110. International Isotopes Basic Information
Table 111. International Isotopes Nuclear Drug for Therapeutic Product Overview
Table 112. International Isotopes Nuclear Drug for Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. International Isotopes Business Overview
Table 114. International Isotopes Recent Developments
Table 115. Mundipharma Basic Information
Table 116. Mundipharma Nuclear Drug for Therapeutic Product Overview
Table 117. Mundipharma Nuclear Drug for Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Mundipharma Business Overview
Table 119. Mundipharma Recent Developments
Table 120. Global Nuclear Drug for Therapeutic Sales Forecast by Region (2026-2035) & (K MT)
Table 121. Global Nuclear Drug for Therapeutic Market Size Forecast by Region (2026-2035) & (M USD)
Table 122. North America Nuclear Drug for Therapeutic Sales Forecast by Country (2026-2035) & (K MT)
Table 123. North America Nuclear Drug for Therapeutic Market Size Forecast by Country (2026-2035) & (M USD)
Table 124. Europe Nuclear Drug for Therapeutic Sales Forecast by Country (2026-2035) & (K MT)
Table 125. Europe Nuclear Drug for Therapeutic Market Size Forecast by Country (2026-2035) & (M USD)
Table 126. Asia Pacific Nuclear Drug for Therapeutic Sales Forecast by Region (2026-2035) & (K MT)
Table 127. Asia Pacific Nuclear Drug for Therapeutic Market Size Forecast by Region (2026-2035) & (M USD)
Table 128. South America Nuclear Drug for Therapeutic Sales Forecast by Country (2026-2035) & (K MT)
Table 129. South America Nuclear Drug for Therapeutic Market Size Forecast by Country (2026-2035) & (M USD)
Table 130. Middle East and Africa Nuclear Drug for Therapeutic Sales Forecast by Country (2026-2035) & (Units)
Table 131. Middle East and Africa Nuclear Drug for Therapeutic Market Size Forecast by Country (2026-2035) & (M USD)
Table 132. Global Nuclear Drug for Therapeutic Sales Forecast by Type (2026-2035) & (K MT)
Table 133. Global Nuclear Drug for Therapeutic Market Size Forecast by Type (2026-2035) & (M USD)
Table 134. Global Nuclear Drug for Therapeutic Price Forecast by Type (2026-2035) & (USD/KG)
Table 135. Global Nuclear Drug for Therapeutic Sales (K MT) Forecast by Application (2026-2035)
Table 136. Global Nuclear Drug for Therapeutic Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Nuclear Drug for Therapeutic Market Size by Type (M USD)
Table 4. Global Nuclear Drug for Therapeutic Market Size by Application
Table 5. Nuclear Drug for Therapeutic Market Size Comparison by Region (M USD)
Table 6. Global Nuclear Drug for Therapeutic Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Nuclear Drug for Therapeutic Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Nuclear Drug for Therapeutic Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Nuclear Drug for Therapeutic Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Drug for Therapeutic as of 2025)
Table 11. Global Market Nuclear Drug for Therapeutic Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Nuclear Drug for Therapeutic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Nuclear Drug for Therapeutic Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Nuclear Drug for Therapeutic Sales by Type (K MT)
Table 27. Global Nuclear Drug for Therapeutic Market Size by Type (M USD)
Table 28. Global Nuclear Drug for Therapeutic Sales (K MT) by Type (2020-2025)
Table 29. Global Nuclear Drug for Therapeutic Sales Market Share by Type (2020-2025)
Table 30. Global Nuclear Drug for Therapeutic Market Size (M USD) by Type (2020-2025)
Table 31. Global Nuclear Drug for Therapeutic Market Share by Type (2020-2025)
Table 32. Global Nuclear Drug for Therapeutic Price (USD/KG) by Type (2020-2025)
Table 33. Global Nuclear Drug for Therapeutic Sales (K MT) by Application
Table 34. Global Nuclear Drug for Therapeutic Market Size by Application
Table 35. Global Nuclear Drug for Therapeutic Sales by Application (2020-2025) & (K MT)
Table 36. Global Nuclear Drug for Therapeutic Sales Market Share by Application (2020-2025)
Table 37. Global Nuclear Drug for Therapeutic Market Size by Application (2020-2025) & (M USD)
Table 38. Global Nuclear Drug for Therapeutic Market Share by Application (2020-2025)
Table 39. Global Nuclear Drug for Therapeutic Sales Growth Rate by Application (2020-2025)
Table 40. Global Nuclear Drug for Therapeutic Sales by Region (2020-2025) & (K MT)
Table 41. Global Nuclear Drug for Therapeutic Sales Market Share by Region (2020-2025)
Table 42. Global Nuclear Drug for Therapeutic Market Size by Region (2020-2025) & (M USD)
Table 43. Global Nuclear Drug for Therapeutic Market Size by Region (2020-2025)
Table 44. North America Nuclear Drug for Therapeutic Sales by Country (2020-2025) & (K MT)
Table 45. North America Nuclear Drug for Therapeutic Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Nuclear Drug for Therapeutic Sales by Country (2020-2025) & (K MT)
Table 47. Europe Nuclear Drug for Therapeutic Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Nuclear Drug for Therapeutic Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Nuclear Drug for Therapeutic Market Size by Region (2020-2025) & (M USD)
Table 50. South America Nuclear Drug for Therapeutic Sales by Country (2020-2025) & (K MT)
Table 51. South America Nuclear Drug for Therapeutic Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Nuclear Drug for Therapeutic Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Nuclear Drug for Therapeutic Market Size by Region (2020-2025) & (M USD)
Table 54. Global Nuclear Drug for Therapeutic Production (K MT) by Region(2020-2025)
Table 55. Global Nuclear Drug for Therapeutic Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Nuclear Drug for Therapeutic Revenue Market Share by Region (2020-2025)
Table 57. Global Nuclear Drug for Therapeutic Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Nuclear Drug for Therapeutic Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Nuclear Drug for Therapeutic Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Nuclear Drug for Therapeutic Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Nuclear Drug for Therapeutic Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Bayer Basic Information
Table 63. Bayer Nuclear Drug for Therapeutic Product Overview
Table 64. Bayer Nuclear Drug for Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Bayer Business Overview
Table 66. Bayer SWOT Analysis
Table 67. Bayer Recent Developments
Table 68. Novartis Basic Information
Table 69. Novartis Nuclear Drug for Therapeutic Product Overview
Table 70. Novartis Nuclear Drug for Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Novartis Business Overview
Table 72. Novartis SWOT Analysis
Table 73. Novartis Recent Developments
Table 74. China Isotope and Radiation Basic Information
Table 75. China Isotope and Radiation Nuclear Drug for Therapeutic Product Overview
Table 76. China Isotope and Radiation Nuclear Drug for Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. China Isotope and Radiation Business Overview
Table 78. China Isotope and Radiation SWOT Analysis
Table 79. China Isotope and Radiation Recent Developments
Table 80. Dongcheng Basic Information
Table 81. Dongcheng Nuclear Drug for Therapeutic Product Overview
Table 82. Dongcheng Nuclear Drug for Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Dongcheng Business Overview
Table 84. Dongcheng Recent Developments
Table 85. Q BioMed Basic Information
Table 86. Q BioMed Nuclear Drug for Therapeutic Product Overview
Table 87. Q BioMed Nuclear Drug for Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Q BioMed Business Overview
Table 89. Q BioMed Recent Developments
Table 90. Curium Pharmaceuticals Basic Information
Table 91. Curium Pharmaceuticals Nuclear Drug for Therapeutic Product Overview
Table 92. Curium Pharmaceuticals Nuclear Drug for Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Curium Pharmaceuticals Business Overview
Table 94. Curium Pharmaceuticals Recent Developments
Table 95. Jubilant Radiopharma Basic Information
Table 96. Jubilant Radiopharma Nuclear Drug for Therapeutic Product Overview
Table 97. Jubilant Radiopharma Nuclear Drug for Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Jubilant Radiopharma Business Overview
Table 99. Jubilant Radiopharma Recent Developments
Table 100. Lantheus Basic Information
Table 101. Lantheus Nuclear Drug for Therapeutic Product Overview
Table 102. Lantheus Nuclear Drug for Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Lantheus Business Overview
Table 104. Lantheus Recent Developments
Table 105. Aurobindo Pharma Basic Information
Table 106. Aurobindo Pharma Nuclear Drug for Therapeutic Product Overview
Table 107. Aurobindo Pharma Nuclear Drug for Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Aurobindo Pharma Business Overview
Table 109. Aurobindo Pharma Recent Developments
Table 110. International Isotopes Basic Information
Table 111. International Isotopes Nuclear Drug for Therapeutic Product Overview
Table 112. International Isotopes Nuclear Drug for Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. International Isotopes Business Overview
Table 114. International Isotopes Recent Developments
Table 115. Mundipharma Basic Information
Table 116. Mundipharma Nuclear Drug for Therapeutic Product Overview
Table 117. Mundipharma Nuclear Drug for Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Mundipharma Business Overview
Table 119. Mundipharma Recent Developments
Table 120. Global Nuclear Drug for Therapeutic Sales Forecast by Region (2026-2035) & (K MT)
Table 121. Global Nuclear Drug for Therapeutic Market Size Forecast by Region (2026-2035) & (M USD)
Table 122. North America Nuclear Drug for Therapeutic Sales Forecast by Country (2026-2035) & (K MT)
Table 123. North America Nuclear Drug for Therapeutic Market Size Forecast by Country (2026-2035) & (M USD)
Table 124. Europe Nuclear Drug for Therapeutic Sales Forecast by Country (2026-2035) & (K MT)
Table 125. Europe Nuclear Drug for Therapeutic Market Size Forecast by Country (2026-2035) & (M USD)
Table 126. Asia Pacific Nuclear Drug for Therapeutic Sales Forecast by Region (2026-2035) & (K MT)
Table 127. Asia Pacific Nuclear Drug for Therapeutic Market Size Forecast by Region (2026-2035) & (M USD)
Table 128. South America Nuclear Drug for Therapeutic Sales Forecast by Country (2026-2035) & (K MT)
Table 129. South America Nuclear Drug for Therapeutic Market Size Forecast by Country (2026-2035) & (M USD)
Table 130. Middle East and Africa Nuclear Drug for Therapeutic Sales Forecast by Country (2026-2035) & (Units)
Table 131. Middle East and Africa Nuclear Drug for Therapeutic Market Size Forecast by Country (2026-2035) & (M USD)
Table 132. Global Nuclear Drug for Therapeutic Sales Forecast by Type (2026-2035) & (K MT)
Table 133. Global Nuclear Drug for Therapeutic Market Size Forecast by Type (2026-2035) & (M USD)
Table 134. Global Nuclear Drug for Therapeutic Price Forecast by Type (2026-2035) & (USD/KG)
Table 135. Global Nuclear Drug for Therapeutic Sales (K MT) Forecast by Application (2026-2035)
Table 136. Global Nuclear Drug for Therapeutic Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Nuclear Drug for Therapeutic
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Nuclear Drug for Therapeutic Market Size (M USD), 2025-2035
Figure 5. Global Nuclear Drug for Therapeutic Market Size (M USD) (2020-2035)
Figure 6. Global Nuclear Drug for Therapeutic Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Nuclear Drug for Therapeutic Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Nuclear Drug for Therapeutic Product Life Cycle
Figure 13. Nuclear Drug for Therapeutic Sales Share by Manufacturers in 2025
Figure 14. Global Nuclear Drug for Therapeutic Revenue Share by Manufacturers in 2025
Figure 15. Nuclear Drug for Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Nuclear Drug for Therapeutic Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Nuclear Drug for Therapeutic Revenue in 2025
Figure 18. Industry Chain Map of Nuclear Drug for Therapeutic
Figure 19. Global Nuclear Drug for Therapeutic Market PEST Analysis
Figure 20. Global Nuclear Drug for Therapeutic Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Nuclear Drug for Therapeutic Market Share by Type
Figure 27. Sales Market Share of Nuclear Drug for Therapeutic by Type (2020-2025)
Figure 28. Sales Market Share of Nuclear Drug for Therapeutic by Type in 2025
Figure 29. Market Share of Nuclear Drug for Therapeutic by Type (2020-2025)
Figure 30. Market Share of Nuclear Drug for Therapeutic by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Nuclear Drug for Therapeutic Market Share by Application
Figure 33. Global Nuclear Drug for Therapeutic Sales Market Share by Application (2020-2025)
Figure 34. Global Nuclear Drug for Therapeutic Sales Market Share by Application in 2025
Figure 35. Global Nuclear Drug for Therapeutic Market Share by Application (2020-2025)
Figure 36. Global Nuclear Drug for Therapeutic Market Share by Application in 2025
Figure 37. Global Nuclear Drug for Therapeutic Sales Growth Rate by Application (2020-2025)
Figure 38. Global Nuclear Drug for Therapeutic Sales Market Share by Region (2020-2025)
Figure 39. Global Nuclear Drug for Therapeutic Market Size by Region (2020-2025)
Figure 40. North America Nuclear Drug for Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Nuclear Drug for Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Nuclear Drug for Therapeutic Sales Market Share by Country in 2024
Figure 43. North America Nuclear Drug for Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Nuclear Drug for Therapeutic Market Size by Country in 2024
Figure 45. U.S. Nuclear Drug for Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Nuclear Drug for Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Nuclear Drug for Therapeutic Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Nuclear Drug for Therapeutic Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Nuclear Drug for Therapeutic Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Nuclear Drug for Therapeutic Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Nuclear Drug for Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Nuclear Drug for Therapeutic Sales Market Share by Country in 2024
Figure 53. Europe Nuclear Drug for Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Nuclear Drug for Therapeutic Market Size by Country in 2024
Figure 55. Germany Nuclear Drug for Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Nuclear Drug for Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Nuclear Drug for Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Nuclear Drug for Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Nuclear Drug for Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Nuclear Drug for Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Nuclear Drug for Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Nuclear Drug for Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Nuclear Drug for Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Nuclear Drug for Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Nuclear Drug for Therapeutic Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Nuclear Drug for Therapeutic Sales Market Share by Region in 2024
Figure 67. Asia Pacific Nuclear Drug for Therapeutic Market Size by Region in 2024
Figure 68. China Nuclear Drug for Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Nuclear Drug for Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Nuclear Drug for Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Nuclear Drug for Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Nuclear Drug for Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Nuclear Drug for Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Nuclear Drug for Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Nuclear Drug for Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Nuclear Drug for Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Nuclear Drug for Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Nuclear Drug for Therapeutic Sales and Growth Rate (K MT)
Figure 79. South America Nuclear Drug for Therapeutic Sales Market Share by Country in 2024
Figure 80. South America Nuclear Drug for Therapeutic Market Size and Growth Rate (M USD)
Figure 81. South America Nuclear Drug for Therapeutic Market Size by Country in 2024
Figure 82. Brazil Nuclear Drug for Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Nuclear Drug for Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Nuclear Drug for Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Nuclear Drug for Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Nuclear Drug for Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Nuclear Drug for Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Nuclear Drug for Therapeutic Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Nuclear Drug for Therapeutic Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Nuclear Drug for Therapeutic Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Nuclear Drug for Therapeutic Market Size by Region in 2024
Figure 92. Saudi Arabia Nuclear Drug for Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Nuclear Drug for Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Nuclear Drug for Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Nuclear Drug for Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Nuclear Drug for Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Nuclear Drug for Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Nuclear Drug for Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Nuclear Drug for Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Nuclear Drug for Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Nuclear Drug for Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Nuclear Drug for Therapeutic Production Market Share by Region (2020-2025)
Figure 103. North America Nuclear Drug for Therapeutic Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Nuclear Drug for Therapeutic Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Nuclear Drug for Therapeutic Production (K MT) Growth Rate (2020-2025)
Figure 106. China Nuclear Drug for Therapeutic Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Nuclear Drug for Therapeutic Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Nuclear Drug for Therapeutic Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Nuclear Drug for Therapeutic Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Nuclear Drug for Therapeutic Market Share Forecast by Type (2026-2035)
Figure 111. Global Nuclear Drug for Therapeutic Sales Forecast by Application (2026-2035)
Figure 112. Global Nuclear Drug for Therapeutic Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Nuclear Drug for Therapeutic
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Nuclear Drug for Therapeutic Market Size (M USD), 2025-2035
Figure 5. Global Nuclear Drug for Therapeutic Market Size (M USD) (2020-2035)
Figure 6. Global Nuclear Drug for Therapeutic Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Nuclear Drug for Therapeutic Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Nuclear Drug for Therapeutic Product Life Cycle
Figure 13. Nuclear Drug for Therapeutic Sales Share by Manufacturers in 2025
Figure 14. Global Nuclear Drug for Therapeutic Revenue Share by Manufacturers in 2025
Figure 15. Nuclear Drug for Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Nuclear Drug for Therapeutic Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Nuclear Drug for Therapeutic Revenue in 2025
Figure 18. Industry Chain Map of Nuclear Drug for Therapeutic
Figure 19. Global Nuclear Drug for Therapeutic Market PEST Analysis
Figure 20. Global Nuclear Drug for Therapeutic Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Nuclear Drug for Therapeutic Market Share by Type
Figure 27. Sales Market Share of Nuclear Drug for Therapeutic by Type (2020-2025)
Figure 28. Sales Market Share of Nuclear Drug for Therapeutic by Type in 2025
Figure 29. Market Share of Nuclear Drug for Therapeutic by Type (2020-2025)
Figure 30. Market Share of Nuclear Drug for Therapeutic by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Nuclear Drug for Therapeutic Market Share by Application
Figure 33. Global Nuclear Drug for Therapeutic Sales Market Share by Application (2020-2025)
Figure 34. Global Nuclear Drug for Therapeutic Sales Market Share by Application in 2025
Figure 35. Global Nuclear Drug for Therapeutic Market Share by Application (2020-2025)
Figure 36. Global Nuclear Drug for Therapeutic Market Share by Application in 2025
Figure 37. Global Nuclear Drug for Therapeutic Sales Growth Rate by Application (2020-2025)
Figure 38. Global Nuclear Drug for Therapeutic Sales Market Share by Region (2020-2025)
Figure 39. Global Nuclear Drug for Therapeutic Market Size by Region (2020-2025)
Figure 40. North America Nuclear Drug for Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Nuclear Drug for Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Nuclear Drug for Therapeutic Sales Market Share by Country in 2024
Figure 43. North America Nuclear Drug for Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Nuclear Drug for Therapeutic Market Size by Country in 2024
Figure 45. U.S. Nuclear Drug for Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Nuclear Drug for Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Nuclear Drug for Therapeutic Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Nuclear Drug for Therapeutic Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Nuclear Drug for Therapeutic Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Nuclear Drug for Therapeutic Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Nuclear Drug for Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Nuclear Drug for Therapeutic Sales Market Share by Country in 2024
Figure 53. Europe Nuclear Drug for Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Nuclear Drug for Therapeutic Market Size by Country in 2024
Figure 55. Germany Nuclear Drug for Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Nuclear Drug for Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Nuclear Drug for Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Nuclear Drug for Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Nuclear Drug for Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Nuclear Drug for Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Nuclear Drug for Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Nuclear Drug for Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Nuclear Drug for Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Nuclear Drug for Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Nuclear Drug for Therapeutic Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Nuclear Drug for Therapeutic Sales Market Share by Region in 2024
Figure 67. Asia Pacific Nuclear Drug for Therapeutic Market Size by Region in 2024
Figure 68. China Nuclear Drug for Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Nuclear Drug for Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Nuclear Drug for Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Nuclear Drug for Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Nuclear Drug for Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Nuclear Drug for Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Nuclear Drug for Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Nuclear Drug for Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Nuclear Drug for Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Nuclear Drug for Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Nuclear Drug for Therapeutic Sales and Growth Rate (K MT)
Figure 79. South America Nuclear Drug for Therapeutic Sales Market Share by Country in 2024
Figure 80. South America Nuclear Drug for Therapeutic Market Size and Growth Rate (M USD)
Figure 81. South America Nuclear Drug for Therapeutic Market Size by Country in 2024
Figure 82. Brazil Nuclear Drug for Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Nuclear Drug for Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Nuclear Drug for Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Nuclear Drug for Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Nuclear Drug for Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Nuclear Drug for Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Nuclear Drug for Therapeutic Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Nuclear Drug for Therapeutic Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Nuclear Drug for Therapeutic Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Nuclear Drug for Therapeutic Market Size by Region in 2024
Figure 92. Saudi Arabia Nuclear Drug for Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Nuclear Drug for Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Nuclear Drug for Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Nuclear Drug for Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Nuclear Drug for Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Nuclear Drug for Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Nuclear Drug for Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Nuclear Drug for Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Nuclear Drug for Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Nuclear Drug for Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Nuclear Drug for Therapeutic Production Market Share by Region (2020-2025)
Figure 103. North America Nuclear Drug for Therapeutic Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Nuclear Drug for Therapeutic Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Nuclear Drug for Therapeutic Production (K MT) Growth Rate (2020-2025)
Figure 106. China Nuclear Drug for Therapeutic Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Nuclear Drug for Therapeutic Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Nuclear Drug for Therapeutic Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Nuclear Drug for Therapeutic Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Nuclear Drug for Therapeutic Market Share Forecast by Type (2026-2035)
Figure 111. Global Nuclear Drug for Therapeutic Sales Forecast by Application (2026-2035)
Figure 112. Global Nuclear Drug for Therapeutic Market Share Forecast by Application (2026-2035)
